ATR
AptarGroup, Inc. NYSE Listed Apr 23, 1993$125.07
Mkt Cap $8.0B
52w Low $103.23
35.8% of range
52w High $164.28
50d MA $128.63
200d MA $130.31
P/E (TTM)
19.9x
EV/EBITDA
11.0x
P/B
2.9x
Debt/Equity
0.6x
ROE
14.7%
P/FCF
26.8x
RSI (14)
—
ATR (14)
—
Beta
0.49
50d MA
$128.63
200d MA
$130.31
Avg Volume
528.1K
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
265 Exchange Drive · Crystal Lake, IL 60014 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 1.15 | 1.19 | +3.5% | 123.68 | +2.9% | -3.8% | +1.3% | +1.2% | +0.5% | +2.0% | — |
| Feb 5, 2026 | AMC | 1.24 | 1.25 | +0.8% | 123.98 | +2.9% | +8.3% | +3.1% | +1.2% | -0.1% | +0.4% | — |
| Oct 30, 2025 | AMC | 1.57 | 1.62 | +3.2% | 124.36 | -7.3% | -6.7% | -2.5% | +0.9% | +1.2% | +0.5% | — |
| Jul 31, 2025 | AMC | 1.58 | 1.66 | +5.1% | 157.14 | -0.1% | -10.0% | -1.6% | +0.8% | -1.2% | +1.4% | — |
| May 1, 2025 | AMC | 1.16 | 1.20 | +3.4% | 148.28 | +3.2% | +2.5% | -0.3% | -0.4% | +0.3% | +1.3% | — |
| Feb 6, 2025 | AMC | 1.28 | 1.52 | +18.8% | 156.45 | +0.7% | -8.5% | +0.1% | -0.7% | -0.4% | +0.8% | — |
| Oct 24, 2024 | AMC | 1.42 | 1.49 | +4.9% | 166.55 | +1.4% | +1.4% | +0.1% | -0.2% | +0.2% | -0.7% | — |
| Jul 25, 2024 | AMC | 1.36 | 1.37 | +0.7% | 141.49 | +1.2% | +3.7% | +0.8% | -1.4% | +0.8% | +0.0% | — |
| Apr 25, 2024 | AMC | 1.15 | 1.26 | +9.6% | 140.18 | +1.3% | +2.2% | +2.1% | -1.4% | +0.7% | +0.4% | — |
| Feb 8, 2024 | AMC | 1.12 | 1.21 | +8.0% | 132.12 | -0.0% | +5.2% | -1.0% | -1.2% | +0.9% | -1.6% | — |
| Oct 25, 2023 | AMC | 1.27 | 1.39 | +9.4% | 122.37 | -0.9% | +0.9% | -1.8% | +0.8% | +0.1% | +0.5% | — |
| Jul 27, 2023 | AMC | 1.14 | 1.23 | +7.9% | 119.14 | +2.8% | +3.9% | -1.9% | +0.8% | -0.2% | -1.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $123.97 | $124.26 | +0.2% | -2.3% | +2.5% | +0.0% | +1.3% | -0.9% |
| Jan 6 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $123.00 | $122.22 | -0.6% | -2.0% | -0.1% | +1.7% | +1.2% | +1.0% |
| Nov 3 | Baird | Maintains | Outperform → Outperform | — | $116.01 | $116.09 | +0.1% | -2.5% | +0.9% | +1.2% | +0.5% | +0.1% |
| Nov 3 | Wells Fargo | Maintains | Overweight → Overweight | — | $116.01 | $116.09 | +0.1% | -2.5% | +0.9% | +1.2% | +0.5% | +0.1% |
| Sep 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $137.05 | $136.13 | -0.7% | -0.6% | +0.6% | -1.4% | -0.3% | +0.3% |
| Aug 4 | Raymond James | Maintains | Outperform → Outperform | — | $141.35 | $143.12 | +1.3% | -1.6% | +0.8% | -1.2% | +1.4% | +0.2% |
| Aug 4 | Wells Fargo | Maintains | Overweight → Overweight | — | $141.35 | $143.12 | +1.3% | -1.6% | +0.8% | -1.2% | +1.4% | +0.2% |
| Jul 18 | Wells Fargo | Maintains | Overweight → Overweight | — | $156.03 | $156.85 | +0.5% | +0.2% | -0.6% | +2.4% | +1.6% | +0.1% |
| Jul 15 | Raymond James | Maintains | Outperform → Outperform | — | $157.56 | $157.74 | +0.1% | -2.2% | +0.5% | +0.7% | +0.2% | -0.6% |
| May 6 | Wells Fargo | Maintains | Overweight → Overweight | — | $151.48 | $150.25 | -0.8% | -0.4% | +0.3% | +1.3% | -0.0% | +1.4% |
| Apr 22 | Raymond James | Maintains | Outperform → Outperform | — | $142.58 | $144.50 | +1.3% | +2.4% | +1.4% | +2.3% | -1.6% | +0.4% |
| Feb 10 | Raymond James | Maintains | Outperform → Outperform | — | $143.18 | $144.26 | +0.8% | +0.1% | -0.7% | -0.4% | +0.8% | +1.4% |
| Feb 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $143.18 | $144.26 | +0.8% | +0.1% | -0.7% | -0.4% | +0.8% | +1.4% |
| Feb 10 | Baird | Maintains | Outperform → Outperform | — | $143.18 | $144.26 | +0.8% | +0.1% | -0.7% | -0.4% | +0.8% | +1.4% |
| Jan 6 | Wells Fargo | Maintains | Overweight → Overweight | — | $155.50 | $154.00 | -1.0% | -1.7% | +0.3% | +0.5% | -0.5% | +0.3% |
| Oct 28 | Baird | Maintains | Outperform → Outperform | — | $168.91 | $169.90 | +0.6% | +0.1% | -0.2% | +0.2% | -0.7% | +0.9% |
| Oct 15 | Wells Fargo | Maintains | Overweight → Overweight | — | $167.19 | $167.32 | +0.1% | +0.9% | -1.6% | +1.1% | +0.4% | -1.4% |
| Oct 14 | Jefferies | Upgrade | Hold → Buy | — | $161.55 | $164.99 | +2.1% | +3.5% | +0.9% | -1.6% | +1.1% | +0.4% |
| Jul 17 | Wells Fargo | Maintains | Overweight → Overweight | — | $144.56 | $144.34 | -0.2% | +0.2% | +1.0% | -0.2% | +0.9% | -0.8% |
| Apr 29 | William Blair | Upgrade | Market Perform → Outperform | — | $143.33 | $144.90 | +1.1% | +2.1% | -1.4% | +0.7% | +0.4% | +0.6% |
| Apr 29 | Wells Fargo | Maintains | Overweight → Overweight | — | $143.33 | $144.90 | +1.1% | +2.1% | -1.4% | +0.7% | +0.4% | +0.6% |
| Apr 29 | Baird | Maintains | Outperform → Outperform | — | $143.33 | $144.90 | +1.1% | +2.1% | -1.4% | +0.7% | +0.4% | +0.6% |
| Mar 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $143.07 | $144.50 | +1.0% | +1.1% | -1.1% | -0.2% | -0.2% | -0.9% |
| Jan 3 | Baird | Upgrade | Neutral → Outperform | — | $122.88 | $125.15 | +1.8% | +2.0% | -0.9% | -0.0% | +0.1% | +0.2% |
| Sep 11 | Wells Fargo | Maintains | Overweight → Overweight | — | $125.31 | $126.99 | +1.3% | +1.4% | -0.4% | -0.9% | +1.1% | -0.7% |
| Jul 17 | Wells Fargo | Maintains | Overweight → Overweight | — | $118.35 | $118.40 | +0.0% | +0.8% | -0.2% | +0.0% | +0.2% | +0.4% |
| May 1 | Baird | Maintains | Neutral → Neutral | — | $118.51 | $119.41 | +0.8% | +2.6% | -1.0% | -0.5% | -0.9% | +2.4% |
| May 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $118.51 | $119.41 | +0.8% | +2.6% | -1.0% | -0.5% | -0.9% | +2.4% |
| May 1 | Deutsche Bank | Maintains | Buy → Buy | — | $118.51 | $119.41 | +0.8% | +2.6% | -1.0% | -0.5% | -0.9% | +2.4% |
| Apr 20 | BofA Securities | Maintains | Buy → Buy | — | $118.71 | $119.00 | +0.2% | +0.3% | +1.3% | -0.2% | -1.9% | -2.0% |
| Feb 21 | Baird | Maintains | Neutral → Neutral | — | $116.69 | $116.50 | -0.2% | -1.4% | -0.3% | -0.1% | +0.2% | +1.7% |
| Feb 21 | Wells Fargo | Maintains | Overweight → Overweight | — | $116.69 | $116.50 | -0.2% | -1.4% | -0.3% | -0.1% | +0.2% | +1.7% |
| Feb 21 | Deutsche Bank | Maintains | Buy → Buy | — | $116.69 | $116.50 | -0.2% | -1.4% | -0.3% | -0.1% | +0.2% | +1.7% |
| Jan 9 | Wells Fargo | Maintains | Overweight → Overweight | — | $114.06 | $114.63 | +0.5% | -0.6% | +0.1% | +0.0% | +0.0% | +0.4% |
| Nov 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $99.15 | $99.60 | +0.5% | -1.9% | -2.5% | -0.1% | +4.3% | +1.7% |
| Oct 18 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $97.32 | $99.25 | +2.0% | +2.0% | -1.1% | -2.2% | +1.5% | +0.4% |
| Oct 12 | Wells Fargo | Maintains | Overweight → Overweight | — | $94.74 | $94.76 | +0.0% | -1.4% | +1.3% | +0.5% | +2.4% | +2.0% |
| Aug 2 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $108.20 | $107.86 | -0.3% | -1.5% | +1.0% | -1.1% | -0.7% | +1.5% |
| Aug 1 | Baird | Maintains | Neutral → Neutral | — | $107.76 | $106.30 | -1.4% | +0.4% | -1.5% | +1.0% | -1.1% | -0.7% |
| Jul 18 | Wells Fargo | Maintains | Overweight → Overweight | — | $100.01 | $100.57 | +0.6% | -1.9% | +3.0% | +0.8% | +1.6% | +0.1% |
| May 2 | Wells Fargo | Maintains | Overweight → Overweight | — | $114.83 | $115.42 | +0.5% | -1.3% | +0.4% | +2.6% | -3.4% | -1.4% |
| Jan 20 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $121.42 | $120.82 | -0.5% | -2.1% | -2.1% | +0.6% | -0.9% | -0.7% |
| Dec 22 | Wells Fargo | Maintains | Overweight → Overweight | — | $115.39 | $115.05 | -0.3% | +0.0% | +0.8% | +3.1% | +1.3% | +0.5% |
| Dec 20 | Deutsche Bank | Maintains | Buy → Buy | — | $115.89 | $114.82 | -0.9% | -1.9% | +1.5% | +0.0% | +0.8% | +3.1% |
| Nov 1 | Deutsche Bank | Maintains | Buy → Buy | — | $120.78 | $119.98 | -0.7% | +3.6% | +1.8% | +0.8% | +0.1% | +2.3% |
| Sep 13 | Baird | Maintains | Neutral → Neutral | — | $125.84 | $125.46 | -0.3% | -0.9% | -0.1% | +0.0% | -1.9% | -0.9% |
| Aug 3 | Wells Fargo | Maintains | Overweight → Overweight | — | $129.91 | $129.55 | -0.3% | -1.0% | -1.4% | +0.6% | +0.7% | +1.3% |
| Aug 2 | William Blair | Downgrade | Outperform → Market Perform | — | $128.92 | $128.44 | -0.4% | +0.8% | -1.0% | -1.4% | +0.6% | +0.7% |
| May 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $152.46 | $152.89 | +0.3% | +1.7% | -0.5% | +1.5% | +0.7% | -1.3% |
| May 3 | BMO Capital | Maintains | Outperform → Outperform | — | $150.81 | $152.16 | +0.9% | +1.1% | +1.7% | -0.5% | +1.5% | +0.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | Hudson Irene ElizabethOff | EVP and Chief Legal Officer | Sell | 842 | $123.45 | $104K | 1,480 | — | — |
| May 7, 2026 | Hudson Irene ElizabethOff | EVP and Chief Legal Officer | Sell | 422 | $123.38 | $52K | 1,480 | — | — |
8-K
AptarGroup, Inc. -- 8-K Filing
AptarGroup's Q1 2026 results declined due to emergency medicine inventory reductions and tough year-over-year comparisons in its prescription division, pressuring near-term revenue growth.
Apr 30
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Athene's new CEO appointment signals leadership transition; investors should monitor strategic direction changes and management's track record executing the company's business plan going forward.
Mar 17
8-K
AptarGroup, Inc. -- 8-K Filing
AptarGroup's fourth quarter 2025 Pharma segment delivered strong growth from elastomeric components and nasal delivery technologies, signaling robust pharmaceutical market demand and positioning ATR for continued expansion.
Feb 5
Data updated apr 24, 2026 7:41pm
· Source: massive.com